This inventor holds 1 USPTO granted patent. Top assignee: Ascepion Pharmaceuticals, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ren Kong and His Patent on Kinase Inhibitors.
Introduction
Ren Kong is an inventor associated with Suzhou, China. His patent work concerns compounds designed to inhibit protein kinases, which are involved in biological processes relevant to disease treatment.
Latest Patents
Kong is named on one patent, 1 patent: “5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors.” The invention describes compounds of Formula I or II and their potential use in treating conditions mediated by protein kinases, including VEGFR2, c-Met, PDGFRβ, c-Kit, CSF1R, and EphA2.
Career Highlights
Kong is associated with Ascepion Pharmaceuticals, Inc. His listed patent reflects work on medicinal compounds targeting several protein kinases.
Collaborations
Qishan Wang and Xinglong Xing are identified as Kong’s coworkers and are also associated with the patent work.
Conclusion
Ren Kong’s patent focuses on bicyclic heteroaryl-containing urea compounds and their potential application as kinase inhibitors for treating kinase-mediated conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile